| Literature DB >> 34109101 |
Arnaud Salmon-Rousseau1, Christelle Auvray2, Quentin Besset1, Claire Briandet3, Claire Desplantes3, Pascal Chavanet1.
Abstract
Bartonella henselae is the bacterial agent responsible for cat scratch disease. This infection is frequently the cause of localized lymphadenitis in children. It is also sometimes responsible for endocarditis, encephalitis, hepatic peliosis and in rare cases osteomyelitis. We describe the second known case of unifocal thoracic osteomyelitis in a 10-year-old child. Copyright:Entities:
Year: 2021 PMID: 34109101 PMCID: PMC8182667 DOI: 10.5194/jbji-6-171-2021
Source DB: PubMed Journal: J Bone Jt Infect ISSN: 2206-3552
Osteomyelitis associated with cat scratch disease, cases reported. Sex: M male; F female. Age: y year. Trunk: C cervical; T thoracic; L lumbar; S sacrum. Blank field: no data; fever in degrees Celsius.
| Year | Authors | Sex/age | The bone | Portions | Lymphadenopathy | Fever | Serology | Antibiotics | Duration of therapy(day) |
|---|---|---|---|---|---|---|---|---|---|
| | | | Column | Limbs | | | | | |
| 1954 | Adams and Hindman (1954) | M/5y | pelvic bone | cervical/inguinal | 38.1 | ||||
| 1959 | Collipp and Koch (1959) | M/4y | pelvic bone | hip | cervical | Penicillin/doxycycline | 9/15 | ||
| 1969 | Carithers et al. (1969) | F/6y | Ve metatarsus | axilla | 38.1 | Erythromycin/chloramphenicol | 15/10 | ||
| 1983 | Carithers (1983) | M/2y | sternum | 38.4 | No treatment | ||||
| 1985 | Johnson et al. (1985) | M/18y | rachis | cervical | |||||
| 1987 | Muszynski et al. (1987) | M/2y | frontal bone | inguinal | 38 | Surgical treatment then cloxacillin | 14 | ||
| 1987 | Walterspiel and Nimityongskul (1987) | F/7y | humerus | dicloxacillin | ? | ||||
| 1989 | Shanon et al. (1989) | M/11y | L4 | axilla | 38.2 | Penicillin-M | ? | ||
| 1990 | Karpathios et al. (1990) | F/8y | T5 | No treatment | |||||
| 1992 | Cohen-Abbo et al. (1992) | M/9y | fronto-parietal bone /T12-L1 | cervical | 40 | Cefalexin/erythromycin/gentamicin | ? | ||
| 1992 | Larsen and Patrick (1992) | F/10y | skull/L4L5 | mandibular/cervical/inguinal | Ceftriaxone then oxacillin | ? | |||
| 1993 | Fretzayas et al. (1993) | M/12y | rachis | Penicillin A | ? | ||||
| 1994 | Bernini et al. (1994) | F/5y | T9 | 38.3 | |||||
| 1994 | Koranyi (1994) | M/4y | rachis | axillar | |||||
| 1994 | Waldvogel et al. (1994) | M/9y | parietal bone | cervical | 40 | IgG 1/1024 | Penicillin-M/fosfomycin | ?/10 | |
| 1996 | Gallemore and Worley (1996) | M/6y | rib/rachis | femur | retro-pharyngeal | ||||
| 1996 | Hopkins et al. (1996) | M/6y | L2 | retro-pharyngeal | yes | ||||
| 1998 | Berg et al. (1998) | F/1y | skull | no | IgG 1/2048 | ||||
| 1998 | Keret et al. (1998) | M/9y | metacarpo-phalangeal | Clindamycin then Cotrimoxazole/rifampicin | 21 14 | ||||
| 1998 | LaRow et al. (1998) | M/10y | pubic/iliac crest | cervical | 40 | IgG 1/1014 | Cefazolin | 14 | |
| 1998 | Ratner et al. (1998) | M/10y | iliac wing/ischium | yes | IgG 1/1024 | ||||
| 1999 | Hulzebos et al. (1999) | F/10y | L2 | cervical | 40 | IgG 1/600 | Ciprofloxacin/fifampicin | 42 | |
| 1999 | Maggiore et al. (1999) | F/7y | humerus | inguinal | IgG 1/256 | Erythromycin | 10 | ||
| 1999 | Robson et al. (1999) | F/9y | T9 | inguinal | 40.8 | IgG 1/2048 | Cotrimoxazole/gentamicin | 84/8 | |
| 2000 | Liapi-Adamidou et al. (2000) | F/7,5y | 8th rib/L2/sacro-iliac /hip | knee | mesenteric | 40 | IgG 1/1024 | cefotaxime | 15 |
| 2000 | Ruess et al. (2000) | F/12y | rachis | sub-mandibular /axillar | 40 | IgG 1/8000 | erythromycin | 21 | |
| 2001 | Fretzayas et al. (2001) | F/9y | rib rachis pelvis | axillar/epithroclear | |||||
| 2001 | Modi et al. (2001) | F/4y | parietal bone 11th 12th Rib, cup, iliac crest | 40 | IgG 1/1024 | Surgical treatment Azithromycin/rifampicin | 28 | ||
| 2002 | Del Santo et al. (2002) | F/2y | L4-L5 | 40 | Azithromycin | ? | |||
| 2002 | Prybis et al. (2002) | M/6y | femur | ||||||
| 2003 | Mirakhur et al. (2003) | F/3y | Orbital osteomelitis | retroperitoneal | 40 | IgG 1/64 | Amoxicillin-clavulanic acid/rifampicin | 35 | |
| 2003 | Rolain et al. (2003) | M/10y | rachis | axillar | Doxycyclin/ciprofloxacin/macrolide | ? | |||
| 2003 | Sakellaris et al. (2003) | F/6y | 10th rib | cervical | 39.8 | IgG 1/8192 | Clarithromycin/gentamicin | 12/8 | |
| 2004 | Ledina et al. (2004) | F/22 months | humerus | cervical | 37.2 | IgG 1/128 | Azithromycin/cotrimoxazole | 20 | |
| 2005 | Abdel-Haq et al. (2005) | M/5y | T4-T5-T7 | axillar | yes | Surgical treatment then Cotrimoxazole/clarithromycin | 5 | ||
| 2005 | Hipp et al. (2005) | M/10y | sacrum ilium | femur | 39 | IgG 1/4096 | Azithromycine | 21 | |
| 2005 | Hipp et al. (2005) | F/3y | tibia | cervical | 40 | IgG 1/512 | Azithromycin | 25 | |
| 2006 | De Kort et al. (2006) | F/9y | sacrolumbar spine | elbow, collarbone, humerus | Cotrimoxazol/rifampicin | 99 | |||
| 2006 | Vermeulen et al. (2006) | F/9y | cervical rachis | 39.6 | Amoxicillin-clavulanic acid | 21 | |||
| 2007 | Hussain and Rathore (2007) | M/3y | T9 | cervical, submandibular | 40 | Macrolide/rifampicin | 42 |
Continued.
| Year | Authors | Sex/age | The bone | Portions | Lymphadenopathy | Fever | Serology | Antibiotics | Duration of therapy (day) |
|---|---|---|---|---|---|---|---|---|---|
| | | | Column | Limbs | | | | | |
| 2007 | Kodama et al. (2007) | F/11y | T3 L4L5 | femur | 39 | IgG 1/1024 | Azithromycin/doxycycline | 28 | |
| 2007 | Rozmanic et al. (2007) | M/11y | 8th rib, T8, iliac bone | inguinal | 40 | IgG 1/8192 | Azithromycin/rifampicin | 42 | |
| 2008 | Ridder-Schröter et al. (2008) | F/12y | humerus | axilla/ epithroclear | 38.3 | IgG 1/1024 | Clarithomycin then clindamycin/rifampicin | 10 11 | |
| 2009 | Tasher et al. (2009) | M/5y | C1-C4-C5 | cervical, submandibular | 38.5 | Surgical treatment then Azithromycine/rifampicin | ? | ||
| 2010 | Kossiva et al. (2010) | F/13y | hip, acetabulum | cervical | IgG 1/1024 | Ceftriaxone | 10 | ||
| 2011 | Boggs and Fisher (2011) | M/11y | cubitus | Azitrhomycin | 21 | ||||
| 2012 | Al-Rahawan et al. (2012) | M/7y | T6-T8 | IgG 1/512 | Azithromycin | 14 | |||
| 2013 | Dusser et al. (2013) | F/13y | hip, sacrum | humerus, femur tibia | 40 | IgG 1/512 | Azithromycin | 28 | |
| 2015 | Lafenetre et al. (2015) | F/13y | T2T3 L4L5 | femur | submandibular | neg | Cotrimoxazole/rifampicin | 21 | |
| 2015 | Knafl et al. (2015) | M/18y | T7 | cervical | 40 | IgG 1/10 000 | Azithromycin/rifampicin | 21 | |
| 2015 | Mirouse et al. (2015) | M/14y | C1-C2 | supracondylar | négative | Amoxicillin-clavulanic acid/ciprofloxacin | 90 | ||
| 2016 | Dornbos et al. (2016) | F/5y | T8-T11 | inguinal | 40 | IgG 1/128 | Azithromycin then Doxycycline/rifampicin | 5 46/25 | |
| 2017 | Harry et al. (2018) | F/9y | sternum, rib, pelvis | hip | 38.8 | IgG 1/512 | Azithromycine | 28 | |
| 2017 | Harry et al. (2018) | F/3y | skull, eye socket, T4 T12 | cervical | 39.4 | IgG 1/1024 | Azithromycine | 28 | |
| 2017 | Rafferty et al. (2017) | M/5y | C7T1 | 38.6 | IgG 1/1024 | Ciprofloxacin/rifampicin | 42 | ||
| 2018 | Akbari et al. (2018) | M/7y | C2-C4 | cervical | IgG 1/1024 | Azithromycin/rifampicin | 42 | ||
| 2018 | Aoki et al. (2018) | F/2y | pelvic bone | femur | cervical | IgG 1/1024 | |||
| 2018 | Donà et al. (2018) | F/12a | temporo-parietal bone | cervical, submandibular | Azithromycin then Cotrimoxaxol/rifampicin | 15 84 | |||
| 2018 | Karski et al. (2018) | F/1.5y | radius | IgG 1/320 | Surgical treatment | ||||
| 2018 | Mathews et al. (2018) | F/12y | elbow, hip | IgG 1/1024 | Azithromycin | 42 | |||
| 2018 | Rafee and English (2018) | F/3y | frontal bone | pre-auricular/inguinal | Azithromycin/rifampicin | 42 | |||
| 2018 | Zellali et al. (2019) | M/3y | pelvic bone, S4–S5 | inguinal | Cefamandol/azithromycin then Amoxicillin-clavulanic acid/rifampicin | 15 42 |